To Get Full Access :

Defencath

Defencath is a catheter lock solution used in adult dialysis patients with central venous catheters. It helps prevent bloodstream infections by combining antimicrobial and anti-clotting effects.

The information outlined in the molecule details section below would help you evaluate Para IV filing opportunities early to secure a first-to-file advantage.

Molecule Details :

  • Molecule Name :

    Taurolidine And Heparin
  • Innovator :

    CORMEDIX INC
  • Approval Date :

    15-Nov-23
  • NCE-1 Date :

    15-Nov-27
  • NCE Date :

    15-Nov-28
  • Dosage Form :

    Single Dose Vial To Instill In Central Venous Catheters
  • Strength :

    3,000 UNITS/3ML (1,000 UNITS/ML);40.5MG/3ML (13.5MG/ML), 5,000 UNITS/5ML (1,000 UNITS/ML);67.5MG/5ML (13.5MG/ML)
  • Therapeutic Category :

    Antimicrobial And Anticoagulant
  • Revenue ($M) :

    NA

Year-wise Projected Sales ($M) :

  • 2025 :

    165
  • 2026 :

    247
  • 2027 :

    274
  • 2028 :

    333
  • 2029 :

    341
  • 2030 :

    400
  • 2031 :

    457
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Partner With Us

Login With

For full access Sign-up / Sign-in using below Methods:

By continuing, you agree to our Terms & Conditions and Privacy Policy. You can review them anytime.

Are you sure want to logout from NCE Grid?